Related Experiment Video
Updated: May 27, 2026

Development, Characterization, and Evaluation of CAGE-based Ionic Liquid Systems for Transdermal Delivery
Published on: September 26, 2025
Chlorinated Withanolides from Withania somnifera
Xiaoqin Tong1, Huaping Zhang, Barbara N Timmermann
1Department of Medicinal Chemistry, University of Kansas, Lawrence, Kansas 66045, United States.
Researchers isolated ten withanolides, including a novel chlorinated compound, from Withania somnifera using spectroscopic methods. X-ray crystallography confirmed the structure of the new chlorinated withanolide.
Area of Science:
- Natural Product Chemistry
- Phytochemistry
- Organic Chemistry
Background:
- Withania somnifera (Solanaceae) is a medicinal plant with a rich history of traditional use.
- The plant is known to produce a diverse array of bioactive secondary metabolites, including withanolides.
Purpose of the Study:
- To isolate and characterize chemical constituents from Withania somnifera.
- To identify novel compounds and elucidate their structures using advanced spectroscopic techniques.
Main Methods:
- Phytochemical investigation of Withania somnifera extract.
- Isolation of compounds using chromatographic techniques.
- Structure elucidation via Infrared spectroscopy (IR), High-Resolution Electrospray Ionization Mass Spectrometry (HRESIMS), and 1D/2D Nuclear Magnetic Resonance (NMR) spectroscopy.
- Confirmation of absolute configuration using X-ray crystallography.
Main Results:
- A new chlorinated withanolide, 6α-chloro-5β,17α-dihydroxywithaferin A, was isolated and characterized.
- Nine known withanolides were identified: 6α-chloro-5β-hydroxywithaferin A, (22R)-5β-formyl-6β,27-dihydroxy-1-oxo-4-norwith-24-enolide, withaferin A, 2,3-dihydrowithaferin A, 3-methoxy-2,3-dihydrowithaferin A, 2,3-didehydrosomnifericin, withanone, withanoside IV, and withanoside X.
- The structure and absolute configuration of the novel chlorinated withanolide were confirmed by X-ray crystallography.
Conclusions:
- The phytochemical analysis of Withania somnifera yielded a diverse range of withanolides, including a previously undescribed chlorinated derivative.
- The structural elucidation employed a comprehensive suite of spectroscopic methods, highlighting the utility of these techniques in natural product discovery.
- The confirmation of the absolute configuration of the new compound provides valuable data for further structure-activity relationship studies.
Related Concept Videos
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
Cholinergic Antagonists: Pharmacokinetics
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal secretions in common...